Wealth Enhancement Advisory Services
VYGR icon

Wealth Enhancement Advisory Services’s Voyager Therapeutics VYGR Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$55.2K Buy
16,052
+5,556
+53% +$21.1K ﹤0.01% 3905
2026
Q1 		$41.6K Buy
+10,496
New +$41.3K ﹤0.01% 3447

Other funds holding VYGR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Wealth Enhancement Advisory Services's VYGR Position: Q2 2026 in Review

Wealth Enhancement Advisory Services increased its Voyager Therapeutics (VYGR) stake by 53% in Q2 2026, buying an estimated $21.1K and bringing the position to 16,052 shares worth $55.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3905.

Wealth Enhancement Advisory Services first reported a position in VYGR in Q1 2026 and has held it in 2 quarters since. 135 funds tracked by Wall St. Rank hold VYGR as of Q2 2026.

  • Wealth Enhancement Advisory Services held 16,052 shares of Voyager Therapeutics worth $55.2K as of Q2 2026.
  • Wealth Enhancement Advisory Services bought 5,556 Voyager Therapeutics shares in Q2 2026, an estimated $21.1K.
  • Voyager Therapeutics made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #3905 holding.
  • Wealth Enhancement Advisory Services first reported a position in Voyager Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 135 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.